Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1995-9-15
|
pubmed:abstractText |
To investigate the mechanism of the antagonistic effect of Na-((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L-prolin amide monohydrate (CAS 131404-34-7, JTP-2942) on reserpine-induced hypothermia, the role of the autonomic nervous system, adrenal gland, and thyroid gland regarding the effects of JTP-2942 has been studied in mice. Both phenoxybenzamine and propranolol significantly attenuated the hyperthermic effect of JTP-2942 on reserpine-induced hypothermia, although neither drug caused complete inhibition. A high dose of hexamethonium also significantly antagonized the hyperthermic effect of JTP-2942. The hyperthermic effect of JTP-2942 was almost abolished by adrenal demedullation. In mice with thiouracil-induced hypothyroidism, both thyrotropin-releasing hormone (TRH) and JTP-2942 significantly increased the rectal temperature. However, the increase induced by TRH was smaller in hypothyroid mice than in control mice, while the temperature increase induced by JTP-2942 was similar in both hypothyroid and control mice. These results suggest that the hyperthermic effect of JTP-2942 is mainly mediated by the adrenal gland and the autonomic nervous system. In addition, the hypothalamic-pituitary-thyroid axis does not regulate the hyperthermic effect of JTP-2942, unlike that of TRH.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Hexamethonium,
http://linkedlifedata.com/resource/pubmed/chemical/JTP 2942,
http://linkedlifedata.com/resource/pubmed/chemical/Phenoxybenzamine,
http://linkedlifedata.com/resource/pubmed/chemical/Propranolol,
http://linkedlifedata.com/resource/pubmed/chemical/Reserpine,
http://linkedlifedata.com/resource/pubmed/chemical/Thiouracil,
http://linkedlifedata.com/resource/pubmed/chemical/Thyrotropin-Releasing Hormone
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0004-4172
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
45
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
708-11
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7646576-Adrenal Medulla,
pubmed-meshheading:7646576-Animals,
pubmed-meshheading:7646576-Body Temperature,
pubmed-meshheading:7646576-Hexamethonium,
pubmed-meshheading:7646576-Hypothermia,
pubmed-meshheading:7646576-Hypothyroidism,
pubmed-meshheading:7646576-Male,
pubmed-meshheading:7646576-Mice,
pubmed-meshheading:7646576-Mice, Inbred ICR,
pubmed-meshheading:7646576-Phenoxybenzamine,
pubmed-meshheading:7646576-Propranolol,
pubmed-meshheading:7646576-Reserpine,
pubmed-meshheading:7646576-Thiouracil,
pubmed-meshheading:7646576-Thyrotropin-Releasing Hormone
|
pubmed:year |
1995
|
pubmed:articleTitle |
Mechanism of the hyperthermic effect of the novel thyrotropin-releasing hormone analogue Na-((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L- prolinamide monohydrate in mice with reserpine-induced hypothermia.
|
pubmed:affiliation |
Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka.
|
pubmed:publicationType |
Journal Article
|